Composition: Ipratropim Bromide I.P. eqv. to Ipratropium Bromide anhydrous 20 mcg + Levo-Salbutamol Tartrate eqv. to Levo Salbutamol 50 mcg + Abs. Alchol 3.40% v/v

  • Provides Longer duration of action and more reassuring safety profile than Ipratropium monotherapy.
  • Shows additive action to produces greater bronchodilation.
  • Free from cardiovascular complications which are generally present in high doses of beta-2 against drugs.


  • COPD
  • Asthma
  • Chronic Bronchitis
Scroll to Top